Last update 21 Nov 2024

Lucicebtide

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Target
Mechanism
CEBPB inhibitors(CCAAT enhancer binding protein beta inhibitors)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationOrphan Drug (EU), Fast Track (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
GB
01 Jul 2020
Advanced Malignant Solid NeoplasmPhase 2
US
01 Jul 2020
Glioblastoma MultiformePhase 2
US
01 Jul 2020
Glioblastoma MultiformePhase 2
GB
01 Jul 2020
Melanoma recurrentPhase 2
GB
01 Jul 2020
Melanoma recurrentPhase 2
US
01 Jul 2020
Metastatic breast cancerPhase 2
US
01 Jul 2020
Metastatic breast cancerPhase 2
GB
01 Jul 2020
Metastatic Prostate CarcinomaPhase 2
GB
01 Jul 2020
Metastatic Prostate CarcinomaPhase 2
US
01 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
(P2 cohort)
(xbliilfikc) = bhxlcehgsr barrknczok (vbuyxjwxkt )
Positive
24 May 2024
(WoO cohort)
(xbliilfikc) = rhwtekfjpz barrknczok (vbuyxjwxkt )
Phase 2
Glioblastoma
Neoadjuvant | Adjuvant
12
(Newly diagnosed GBM)
(cecwqjsjak) = upouwjcbch rphnaotnmk (atsaxvrvnx )
Positive
17 Nov 2023
(Recurrent GBM)
(cecwqjsjak) = xlupyyuuev rphnaotnmk (atsaxvrvnx )
Phase 1
25
(gzanwahtcu) = The only AEs of note were G1-2 histaminergic infusion-related reactions (IRRs), largely pruritis and urticaria xfxzcpvloz (bffuqvfgog )
Positive
02 Jun 2022
Phase 1/2
-
wzdguqfvqg(nkqgqbaskk) = fxtglthcqn xrpfbyqbrc (ixkpsgtmvl )
-
01 Jul 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free